Drug-Free
therapy for congestion and pain relief which can be used alone or in combination with all other existing treatments
Non-Invasive
device automatically activated by skin contact, stimulates internal tissue using precisely modulated acoustic waves
Easy to use
simple and hand-held; our device can be used anywhere, by anyone, as often as needed, with a two minute treatment
Targeted,
rapid relief.
Chronic nasal congestion, a symptom of chronic rhinosinusitis and rhinitis, affects 1 in every 5 people, causing them to experience constant discomfort, pain and fatigue. Current treatments are associated with limited efficacy and safety concerns.
The globally patented* and design-protected BES-1001 device is the first drug-free, non-invasive and connected treatment that provides targeted, rapid relief from nasal congestion and related pain.
Currently in clinical development, BES-1001 is expected to be registered by early 2024.
*Patents: WO2020/245467 and WO2020/245466
How it works
BES-1001 delivers precisely-modulated acoustic energy (PMAE) that gently travels through the tissue to relieve sinus and nasal congestion, pressure and pain.
Applied against the cheekbone
BES-1001 activates upon contact with the skin and produces PMAE that travels into the nasal cavity and sinuses, lasting 1 minute per cheeckbone
Tissue oscillation
PMAE excites the resonant frequency of the sinuses, stimulates nitric oxide release and promotes clearance of the nasal passages.
Inhibiting pain signalling
Acoustic energy activates mechanoreceptors, ‘closing the gate’ to pain fibre signals and inhibiting their transmission to the brain.
Clinical validation of mechanism of action
congested sinuses
76%
faster mucociliary
clearance
2x
better sinus
ventilation
What users are saying about BES-1001
“I have been sleeping for the last 20 years with a CPAP machine, and in case of a cold or infection in my nose, I cannot use the CPAP. I have been using the BES-1001 consistently for 2 years, early in the morning and late at night and during these years I was not affected by any nose infections or cold so I was able to use the CPAP. Now, I always ensure that I carry the BES-1001 with me on all my travels, giving me the confidence and relief of breathing correctly.”
“When I have a cold, I manage to treat it successfully with the BES-1001. The BES-1001 has become a family device.”
“The device was very easy to use and comfortable during treatment. I felt immediately decongested and could breathe better!”
“I am happy to say that using the above device helped me to give up the cortisone nasal spray, and in a very short time”
“For me it is very important the device I feel really better!”
a game-changing medical device company
We are a Swiss medical device company that develops drug-free, non-invasive medical devices for the treatment of high-prevalence chronic nasal and pain conditions. Leveraging our network of international partners, we are committed to developing medical devices that harness the power of PMAE therapy and continue to research its applications in further indications.
We aim to reshape treatment paradigms with ground-breaking therapies that are effective, safe and that meaningfully address patient convenience.
Latest News
February 6, 2023
BioEleSonic attends the Biotechgate Digital Partnering Event | 6-10 February 2023
November 30, 2022
BioEleSonic attends the Biotechgate Digital Partnering Event | 28 November - 2 December 2022
May 2, 2022
SynDermix attends SWISS BIOTECH DAY 2021 proudly presenting BES-1001 | 2 May 2022
November 19, 2021
BioEleSonic virtually attends the 8th China Healthcare Summit
| 16-19 November 2021
November 15, 2021
BioEleSonic attends MEDICA Trade fair 2021 with a stand presenting BES-1001 | 15-18 November 2021